Tvardi Therapeutics (TVRD) Change in Cash (2013 - 2026)

Tvardi Therapeutics has reported Change in Cash for 14 years, with the latest figure at -$883000.0 in Q1 2026.

• Quarterly Change in Cash rose 95.62% year-over-year to -$883000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.4 million (up 233.67% YoY) and the FY2025 annual result came in at -$10.9 million, down 225.13% from the prior year.
• Change in Cash fell to -$883000.0 in Q1 2026 per TVRD's latest filing, from -$684000.0 in the prior quarter.
• Over five years, Change in Cash peaked at $25.4 million in Q2 2022 and troughed at -$20.2 million in Q1 2025.
• A 5-year average of $2.2 million and a median of -$684000.0 in 2025 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 13880.43% in 2022, down 696.34% in 2022.
• Over 5 years, Change in Cash stood at $20.9 million in 2022, then slumped by 153.02% to -$11.1 million in 2023, then jumped by 299.78% to $22.2 million in 2024, then tumbled by 103.08% to -$684000.0 in 2025, then decreased by 29.09% to -$883000.0 in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$883000.0, -$684000.0, and $770000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.